# Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient

> **NCT06993740** · NA · RECRUITING · sponsor: **Dharmais National Cancer Center Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Flap Monitoring
- Inflammation
- Thrombosis
- Oxidative Stress
- Glycocalyx
- Anesthesia
- Surgery
- Flap Ischemia
- Flap Necrosis
- Flap Failure Risk Factors
- Microsurgery

## Interventions

- **DRUG:** NaCl 0,9%
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT06993740
- **Lead sponsor:** Dharmais National Cancer Center Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2026-05-26
- **Final completion:** 2026-08-22
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06993740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06993740, "Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06993740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*